应用蒙特利尔分类对克罗恩病的分级之间的分歧:五国调查研究
Offir Ukashi1,2, Aurelien Amiot3, David Laharie4
1Sheba Medical Center, Institute of Gastroenterology, Ramat-Gan, Israel.
United European gastroenterology journal
|January 18, 2025
概括
胃肠道学家在将蒙特利尔分类用于克罗恩病时表现出显著的分歧,特别是在疾病行为方面. 这凸显了需要更好的教育或修订的标准,以提高诊断的一致性.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 蒙特利尔分类,成立于2005年,是基于发病年龄,位置,行为和上/周围卷入的克罗恩病分类的标准工具.
- 随着治疗策略的不断发展,蒙特利尔分类的实际应用和准确性需要重新评估.
研究的目的:
- 评估胃肠病学家在应用蒙特利尔克罗恩病分类表现的表现.
- 为了比较人类专家与大型语言模型 (LLM) 在分类克罗恩病病例中的准确性.
主要方法:
- 一项国际在线调查与胃肠道科医生进行,分类了20个理论克罗恩病病例.
- 专家和研究员的专家委员会协议率被计算出来,并与三个LLM (ChatGPT-4,Claude-3,Gemini-1.5) 相比.
- 弗莱斯·卡帕公司被用来评估集团内部的协议,多数投票<75%表明显著的分歧.
主要成果:
- 专家们对专家委员会意见的同意率 (58%) 比研究员/年轻专家 (49%) 和法学士 (18%) 高.
- 疾病行为分类是最具挑战性的方面,与整体分类相比,所有组的同意率都较低.
- 值得注意的分歧集中在阻塞性症状,囊内镜检查结果和疾病表型的治疗可逆性.
结论:
- 在应用蒙特利尔分类对克罗恩病,特别是关于疾病行为存在显著的分级者之间的分歧.
- 建议加强教育举措或对分类的表型标准进行修订,以提高共识和诊断一致性.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
181
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
181
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
314
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
314
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
138
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
138
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Inflammatory Bowel Disease I: Ulcerative Colitis
134
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
134


